Karen Knudsen, enterprise director of the Sidney Kimmel Cancer Center–Jefferson Health, was elected vice president/president-elect of the Association of American Cancer Institutes’ board of directors.
Knudsen, who has been serving as SKCC enterprise director since 2015, governs cancer research and cancer care across 14 hospitals within Jefferson Health.
Under Knudsen’s leadership, SKCC recently was evaluated as “Outstanding” in its most recent NCI Cancer Center Support Grant renewal. It was one of only three cancer centers to rank “Exceptional” by the NCI for Community Outreach and Engagement.
Knudsen is also the Hilary Koprowski Chair, Department of Cancer Biology at Thomas Jefferson University, and Professor of Cancer Biology, Urology, Medical Oncology, and Radiation Oncology. Her translational research centers on prostate cancer and has contributed to new mechanisms for treatment of advanced disease.
A member of AACI’s board of directors since 2016, Knudsen was program chair of the association’s 2017 annual meeting. She also serves on review, advisory, and elected panels for the NIH, Department of Defense, American Society of Clinical Oncology, American Association for Cancer Research, and is editor-in-chief of the journal Molecular Cancer Research.
Knudsen’s two-year term will begin Sept. 30 during the AACI/Cancer Center Administrators Forum annual meeting in Chicago.
